Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-01 @ 11:27 AM
Study NCT ID:
NCT02682420
Status:
TERMINATED
Last Update Posted:
2025-12-11
First Post:
2016-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
everlinQ endoAVF Post Market Study
Sponsor:
C. R. Bard
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-05
First Submit QC Date:
None
Study First Post Date:
2016-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-25
Results First Submit QC Date:
None
Results First Post Date:
2021-11-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED